Skip to content

At the Telethon Kids Institute our researchers are searching for answers to improve the health and wellbeing of children and families affected by some of  the most devastating, complex and common diseases and issues.  At any one time we have more than 200 active research projects and 700 staff and students that include laboratory scientists, clinicians, epidemiologists, bioinformaticians, statisticians, public health professionals and social scientists.

Our research is structured into Research Focus Areas, programs of work and teams.  We are committed to collaboration and work together with other research organisations, clinicians, practitioners, policy makers, consumers and the community to understand the complexity of factors that impact on a child's health and wellbeing and the translation of research findings into action. We actively reward research excellence and offer a range of schemes to support our researchers.

In August 2018, we moved to our new purpose-built facility located within Perth Children’s Hospital on the QEII Medical Centre campus - the largest centre of excellence in healthcare, research and education in the southern hemisphere. With a footprint across seven floors, our new home features more than 7000sqm of work space and 2000sqm of laboratories (including specialty suites, equipment rooms and freezer farms), as well as dedicated clinical suites and a cryogenics facility. Our co-location with the Perth Children’s Hospital will enhance our collaboration with clinicians, nursing staff and other allied health professionals, leading to better care, better treatments and better health and development outcomes for our children and young people.

We are an independent medical research institute based in Perth, Western Australia and affiliated with the State's major universities. Our research is  primarily funded through national and international competitive grants and generously supported by donors and governments.

Study subsites

Check out our study websites

September 2022

Standardization of Epidemiological Surveillance of Group A Streptococcal Pharyngitis

Pharyngitis, more commonly known as sore throat, is caused by viral and/or bacterial infections. Group A Streptococcus (Strep A) is the most common bacterial cause of pharyngitis. Strep A pharyngitis is an acute, self-limiting disease but if undertreated can lead to suppurative complications, nonsuppurative poststreptococcal immune-mediated diseases, and toxigenic presentations.

Published research Infectious Diseases Infectious Diseases Epidemiology Subsite: Wesfarmers Centre of Vaccines and Infectious Diseases Invasive Streptococcus A Disease Healthy Skin and ARF Prevention Strep A Pathogenesis and Diagnostics Strep A & ARF Therapeutics Strep A Vaccines Implementation, Epidemiology & New Horizons
September 2022

Standardization of Epidemiological Surveillance of Acute Poststreptococcal Glomerulonephritis

Acute poststreptococcal glomerulonephritis (APSGN) is an immune complex-induced glomerulonephritis that develops as a sequela of streptococcal infections. This article provides guidelines for the surveillance of APSGN due to group A Streptococcus (Strep A). The primary objectives of APSGN surveillance are to monitor trends in age- and sex-specific incidence, describe the demographic and clinical characteristics of patients with APSGN, document accompanying risk factors, then monitor trends in frequency of complications, illness duration, hospitalization rates, and mortality.

Published research Infectious Diseases Infectious Diseases Epidemiology Subsite: Wesfarmers Centre of Vaccines and Infectious Diseases Subsite: END RHD Invasive Streptococcus A Disease Healthy Skin and ARF Prevention
April 2022

A randomised controlled trial of a novel tramadol chewable tablet: pharmacokinetics and tolerability in children

Tramadol is a bitter atypical opioid analgesic drug and is prescribed to treat postoperative pain in children. However, in many countries there is no licensed paediatric tramadol formulation available. We have formulated a novel chewable chocolate-based drug delivery system for the administration of tramadol to children.

Published research Perioperative Medicine
June 2022

Acute Leukaemia of Ambiguous Lineage Presenting as a Focal Bone Lesion: a Case Report

Acute leukaemia is the most common childhood malignancy. Almost all cases are classified as acute lymphoblastic leukaemia or acute myeloid leukaemia. Acute leukaemia of ambiguous lineage (ALAL) is a rare form of acute leukaemia that cannot be classified by a single lineage. Like other acute leukaemias, ALAL typically presents with nonspecific symptoms such as fatigue, fever, or bleeding.

Children's Cancers Brain Tumour Research Leukaemia Translational Research

Associate Professor Glenn Pearson

Director of First Nations Strategy and Leadership

BA (Education) PhD Candidate

Professor Ben Jackson

Research Theme Head, Brain and Behaviour

BSc (Hons) PhD

Liz Davis

Head, Chronic & Severe Diseases Research Focus Area; Clinical Lead, Diabetes and Obesity Research


Deborah Strickland

Program Head, Immunobiology and Immunotherapeutic Program